Filing Details
- Accession Number:
- 0001886259-22-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-16 18:41:33
- Reporting Period:
- 2022-08-12
- Accepted Time:
- 2022-08-16 18:41:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1482981 | Vita Coco Company Inc. | COCO | Beverages (2080) | 113713156 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1886259 | Kevin Benmoussa | 250 Park Avenue South 7Th Floor New York NY 10003 | Global Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-12 | 56,875 | $10.18 | 67,025 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-08-12 | 56,875 | $12.76 | 10,150 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-08-15 | 30,000 | $10.18 | 40,150 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-08-15 | 10,000 | $15.01 | 30,150 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 16,023 | $14.43 | 14,127 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 3,977 | $13.78 | 10,150 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-08-12 | 56,875 | $0.00 | 56,875 | $10.18 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-08-15 | 30,000 | $0.00 | 30,000 | $10.18 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
56,875 | 2030-02-10 | No | 4 | M | Direct | |
83,750 | 2029-12-16 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $10.18 | 2031-01-11 | 27,300 | 27,300 | Direct | |
Common Stock | Stock Option (Right to Buy) | $15.00 | 2031-10-20 | 49,751 | 49,751 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2031-01-11 | 27,300 | 27,300 | Direct |
2031-10-20 | 49,751 | 49,751 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.50 to $13.02, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.03, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.69, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.99, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Includes (i) 10,000 unvested RSUs that vest in four annual installments starting November 27, 2022 provided that the Reporting Person remains in continuous service on each vesting date and (ii) 150 shares of common stock purchased directly from the issuer's underwriters in a Reserved Share Program.
- The stock option is fully vested and currently exercisable as to 56,875 underlying shares, with the remaining vesting on February 10, 2024.
- The stock option is fully vested and currently exercisable.
- The stock option vests in two equal biennial installments beginning on January 11, 2023.
- The stock option vests in four equal annual installments beginning on November 27, 2022.